Detalhe da pesquisa
1.
PCSD1, a new patient-derived model of bone metastatic prostate cancer, is castrate-resistant in the bone-niche.
J Transl Med
; 12: 275, 2014 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25278011
2.
Reversal of malignant ADAR1 splice isoform switching with Rebecsinib.
Cell Stem Cell
; 30(3): 250-263.e6, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36803553
3.
A PSMA-targeted bispecific antibody for prostate cancer driven by a small-molecule targeting ligand.
Sci Adv
; 7(33)2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34380625
4.
Establishment and Analysis of Three-Dimensional (3D) Organoids Derived from Patient Prostate Cancer Bone Metastasis Specimens and their Xenografts.
J Vis Exp
; (156)2020 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32065165
5.
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma.
Nat Commun
; 8(1): 1922, 2017 12 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29203771
6.
Specific bone region localization of osteolytic versus osteoblastic lesions in a patient-derived xenograft model of bone metastatic prostate cancer.
Asian J Urol
; 3(4): 229-239, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29264191
7.
Increased aldehyde dehydrogenase activity in high-risk chronic lymphocytic leukemia.
Leuk Lymphoma
; 54(2): 400-2, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22784365